Erasca, Inc. (ERAS)
11.64
-0.31
(-2.59%)
USD |
NASDAQ |
Feb 11, 13:55
Erasca EPS Diluted (Quarterly) : -0.1079 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 1.024 |
| Revolution Medicines, Inc. | -1.613 |
| Immuneering Corp. | -0.3772 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.61M |
| Total Expenses (Quarterly) | 30.61M |
| Enterprise Value | 3.150B |
| Earnings Yield | -3.87% |
| Normalized Earnings Yield | -3.671 |